Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
20861
Analysis of the various EcFicTA complexes in solution.
Published 2016“…<p>(<i>a</i>) SEC-MALLS analysis of EcFicTA (green), EcFicTA<sub>E28G</sub> (pink), EcFicT<sub>G55R</sub>A (cyan) and EcFicT<sub>G55R</sub>A<sub>E28G</sub> (purple) reveals in each case a 1:1 complex in solution at an eluting concentration of 15 μM. …”
-
20862
S1 Data -
Published 2024“…Mean and SD of zinc in tissues from control and inoculated gerbils with two isolates of Giardia intestinalis: WB and HGINV. A significant decrease was present in zinc levels. …”
-
20863
-
20864
Related to Fig 3.
Published 2025“…(<b>Q</b>) Tumor growth kinetics recorded a significantly higher growth of BT-474_ZFX<sup>OE</sup> (mean ± SEM, <i>n</i> = 5) than BT-474_VECT<sup>OE</sup> tumors. …”
-
20865
-
20866
Discovery of a Novel Class of d‑Amino Acid Oxidase Inhibitors Using the Schrödinger Computational Platform
Published 2022“…d-Serine is a coagonist of the <i>N</i>-methyl d-aspartate (NMDA) receptor, a key excitatory neurotransmitter receptor. …”
-
20867
-
20868
-
20869
Discovery of a Novel Class of d‑Amino Acid Oxidase Inhibitors Using the Schrödinger Computational Platform
Published 2022“…d-Serine is a coagonist of the <i>N</i>-methyl d-aspartate (NMDA) receptor, a key excitatory neurotransmitter receptor. …”
-
20870
-
20871
Luminal tumors have a deregulated sphingolipid and ganglioside profile and high RICTOR expression.
Published 2025“…(<b>D</b>–<b>H</b>) Absolute quantification (mean ± SEM, <i>n</i> = 5) of GM3 (D), GD3 (E), GD2 (F), GM2 (G), and GM1 (H) gangliosides in luminal tumor tissues and adjacent normal tissues shows an increase in GM3 and GD3 gangliosides and a decrease in GM1 gangliosides in luminal tumor tissues. …”
-
20872
Feijoa F3 inhibits NF-κB activity in A. MEF cells and B. MEF Atg5<sup>-/-</sup> cells.
Published 2015“…A percentage of greater than 100 shows increased inflammatory response in the presence of the ligand when compared to media (no treatment); and a percentage of less than 100 suggests a decrease in the inflammatory response in the presence of the ligand when compared to media (no treatment) meaning that a condition has inhibited NF-κB signaling. …”
-
20873
-
20874
-
20875
Smoking Is Associated with an Increased Risk of Dementia: A Meta-Analysis of Prospective Cohort Studies with Investigation of Potential Effect Modifiers
Published 2015“…<div><p>Background</p><p>Previous studies showed inconsistent results on the association of smoking with all-cause dementia and vascular dementia (VaD), and are limited by inclusion of a small number of studies and unexplained heterogeneity. …”
-
20876
-
20877
-
20878
-
20879
Table_5_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx
Published 2022“…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”
-
20880
Image_5_Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors.jpeg
Published 2021“…Exercise intervention resulted in significant alterations in the level of expression of serum IP-10 (mean difference (MD): 38.02 (95% CI: 0.69 to 75.35)), IL-27 (MD: 249.48 (95% CI: 22.43 to 476.53)), and the vascular injury biomarkers, ICAM-1 (MD: 1.05 (95% CI: 1.07 to 1.66)), and VCAM-1 (MD: 1.51 (95% CI: 1.04 to 2.14)) at T1. A significant increase in eotaxin-3 (MD: 2.59 (95% CI: 0.23 to 4.96)), IL-15 (MD: 0.27 (95% CI: 0 to 0.54)) and decrease in bFGF (MD: 1.62 (95% CI: -2.99 to 0.26)) expression was observed between control and intervention cohorts at T2 (p<0.05).…”